These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22586700)

  • 1. Absence of bone sialoprotein (BSP) impairs primary bone formation and resorption: the marrow ablation model under PTH challenge.
    Wade-Gueye NM; Boudiffa M; Vanden-Bossche A; Laroche N; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
    Bone; 2012 May; 50(5):1064-73. PubMed ID: 22586700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of OPN in BSP knockout mice does not correct bone hypomineralization but results in high bone turnover.
    Bouleftour W; Juignet L; Verdière L; Machuca-Gayet I; Thomas M; Laroche N; Vanden-Bossche A; Farlay D; Thomas C; Gineyts E; Concordet JP; Renaud JB; Aubert D; Teixeira M; Peyruchaud O; Vico L; Lafage-Proust MH; Follet H; Malaval L
    Bone; 2019 Mar; 120():411-422. PubMed ID: 30529011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Shaft Revascularization After Marrow Ablation Is Dramatically Accelerated in BSP-/- Mice, Along With Faster Hematopoietic Recolonization.
    Bouleftour W; Granito RN; Vanden-Bossche A; Sabido O; Roche B; Thomas M; Linossier MT; Aubin JE; Lafage-Proust MH; Vico L; Malaval L
    J Cell Physiol; 2017 Sep; 232(9):2528-2537. PubMed ID: 27704558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking the expression of both bone sialoprotein (BSP) and osteopontin (OPN) impairs the anabolic action of PTH in mouse calvaria bone.
    Bouleftour W; Bouet G; Granito RN; Thomas M; Linossier MT; Vanden-Bossche A; Aubin JE; Lafage-Proust MH; Vico L; Malaval L
    J Cell Physiol; 2015 Mar; 230(3):568-77. PubMed ID: 25160656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice lacking bone sialoprotein (BSP) lose bone after ovariectomy and display skeletal site-specific response to intermittent PTH treatment.
    Wade-Gueye NM; Boudiffa M; Laroche N; Vanden-Bossche A; Fournier C; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
    Endocrinology; 2010 Nov; 151(11):5103-13. PubMed ID: 20844009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro.
    Boudiffa M; Wade-Gueye NM; Guignandon A; Vanden-Bossche A; Sabido O; Aubin JE; Jurdic P; Vico L; Lafage-Proust MH; Malaval L
    J Bone Miner Res; 2010 Dec; 25(12):2669-79. PubMed ID: 20812227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal development of mice lacking bone sialoprotein (BSP)--impairment of long bone growth and progressive establishment of high trabecular bone mass.
    Bouleftour W; Boudiffa M; Wade-Gueye NM; Bouët G; Cardelli M; Laroche N; Vanden-Bossche A; Thomas M; Bonnelye E; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
    PLoS One; 2014; 9(5):e95144. PubMed ID: 24816232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralization defects in cementum and craniofacial bone from loss of bone sialoprotein.
    Foster BL; Ao M; Willoughby C; Soenjaya Y; Holm E; Lukashova L; Tran AB; Wimer HF; Zerfas PM; Nociti FH; Kantovitz KR; Quan BD; Sone ED; Goldberg HA; Somerman MJ
    Bone; 2015 Sep; 78():150-64. PubMed ID: 25963390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
    Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
    J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice.
    Valverde P; Zhang J; Fix A; Zhu J; Ma W; Tu Q; Chen J
    J Bone Miner Res; 2008 Nov; 23(11):1775-88. PubMed ID: 18597627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow.
    Jacome-Galarza CE; Lee SK; Lorenzo JA; Aguila HL
    J Bone Miner Res; 2011 Jun; 26(6):1207-16. PubMed ID: 21611963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of osteoclastogenic factor transcripts in osteoblast-like UMR-106 cells after exposure to FGF-23 or FGF-23 combined with parathyroid hormone.
    Teerapornpuntakit J; Wongdee K; Krishnamra N; Charoenphandhu N
    Cell Biol Int; 2016 Mar; 40(3):329-40. PubMed ID: 26694880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
    Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
    J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures.
    Soma S; Matsumoto S; Takano-Yamamoto T
    Arch Oral Biol; 1997 Mar; 42(3):205-11. PubMed ID: 9188990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
    Ma YL; Cain RL; Halladay DL; Yang X; Zeng Q; Miles RR; Chandrasekhar S; Martin TJ; Onyia JE
    Endocrinology; 2001 Sep; 142(9):4047-54. PubMed ID: 11517184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel bioactivity of phosvitin in connective tissue and bone organogenesis revealed by live calvarial bone organ culture models.
    Liu J; Czernick D; Lin SC; Alasmari A; Serge D; Salih E
    Dev Biol; 2013 Sep; 381(1):256-75. PubMed ID: 23791550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
    Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
    Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leonurus sibiricus L. ethanol extract promotes osteoblast differentiation and inhibits osteoclast formation.
    Kim JH; Kim M; Jung HS; Sohn Y
    Int J Mol Med; 2019 Sep; 44(3):913-926. PubMed ID: 31524244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.